AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies

BERWYN, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, distinguishes itself as the partner of choice for rare disease pharmaceutical manufacturers, offering a patient-first, customizable model that supports the successful commercialization and distribution of specialty and rare disease therapies. This commitment is showcased in a three-part series of AscellaHealth Podcast Pulse, featuring Donovan Quill, Chief Strategy Officer, AscellaHealth and Charlie Gayer, Chief Commercial Officer, BioCryst Pharmaceuticals, who highlight the value of these adaptable, patient-focused solutions.

To read more, click here